Compare IOVA & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | LNC |
|---|---|---|
| Founded | 2007 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.0B |
| IPO Year | 2008 | 1994 |
| Metric | IOVA | LNC |
|---|---|---|
| Price | $14.11 | $40.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $14.40 | ★ $47.83 |
| AVG Volume (30 Days) | ★ 12.5M | 1.6M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 4.46% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $18,212,000,000.00 |
| Revenue This Year | $56.63 | $8.34 |
| Revenue Next Year | $42.41 | $3.80 |
| P/E Ratio | ★ N/A | $7.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.76 | $32.18 |
| 52 Week High | $15.37 | $47.67 |
| Indicator | IOVA | LNC |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 49.30 |
| Support Level | $3.57 | $38.83 |
| Resistance Level | $15.00 | $42.68 |
| Average True Range (ATR) | 0.92 | 0.99 |
| MACD | -0.17 | 0.08 |
| Stochastic Oscillator | 58.17 | 48.87 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.